CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is engaged in developing antibody therapeutics based on probody technology platform.
$7.60 -0.62 (-7.49%)
As of 03/04/2021 15:59:55 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.